Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection
Top Cited Papers
- 27 October 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (3), e1343-e1353
- https://doi.org/10.1210/clinem/dgaa733
Abstract
Background: The role of vitamin D status in COVID-19 patients is a matter of debate. Objectives: To assess serum 25-hydroxyvitamin D (25OHD) levels in hospitalized patients with COVID-19 and to analyze the possible influence of vitamin D status on disease severity. Methods: Retrospective case–control study of 216 COVID-19 patients and 197 population-based controls. Serum 25OHD levels were measured in both groups. The association of serum 25OHD levels with COVID-19 severity (admission to the intensive care unit, requirements for mechanical ventilation, or mortality) was also evaluated. Results: Of the 216 patients, 19 were on vitamin D supplements and were analyzed separately. In COVID-19 patients, mean ± standard deviation 25OHD levels were 13.8 ± 7.2 ng/mL, compared with 20.9 ± 7.4 ng/mL in controls (P < .0001). 25OHD values were lower in men than in women. Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (P < .0001). 25OHD inversely correlates with serum ferritin (P = .013) and D-dimer levels (P = .027). Vitamin D-deficient COVID-19 patients had a greater prevalence of hypertension and cardiovascular diseases, raised serum ferritin and troponin levels, as well as a longer length of hospital stay than those with serum 25OHD levels ≥20 ng/mL. No causal relationship was found between vitamin D deficiency and COVID-19 severity as a combined endpoint or as its separate components. Conclusions: 25OHD levels are lower in hospitalized COVID-19 patients than in population-based controls and these patients had a higher prevalence of deficiency. We did not find any relationship between vitamin D concentrations or vitamin deficiency and the severity of the disease.Keywords
Funding Information
- Instituto de Salud Carlos III (PI18/00762)
- Ministerio de Economía y Competitividad
This publication has 36 references indexed in Scilit:
- Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology, 2013
- Vitamin D: a negative acute phase reactantJournal of Clinical Pathology, 2013
- Age and low levels of circulating vitamin D are associated with impaired innate immune functionJournal of Leukocyte Biology, 2012
- Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1The Journal of Immunology, 2012
- An update on vitamin D and human immunityClinical Endocrinology, 2012
- Vitamin D deficiency in Spain: a population-based cohort studyEuropean Journal of Clinical Nutrition, 2010
- Metabolic syndrome and bone metabolismMenopause, 2010
- 1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3The Journal of Immunology, 2009
- Vitamin D and the elderlyClinical Endocrinology, 2005
- Serum vitamin D concentrations among elderly people in EuropeThe Lancet, 1995